Cryptococcus neoformans is resistant to Surfactant protein A mediated host defense mechanisms

PLoS ONE

Volumn 2, Issue 12, 2007, Pages

  Giles, Steven S ^a   Zaas, Aimee K ^a   Reidy, Mike F ^a   Perfect, John R ^a   Wright, Jo Rae ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G; SURFACTANT PROTEIN A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DISEASE COURSE; ENCAPSULATION; FUNGAL STRAIN; FUNGAL VIRULENCE; HOST RESISTANCE; IMMUNE RESPONSE; IN VIVO STUDY; INCUBATION TIME; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; WILD TYPE; ANIMAL; GENETICS; IMMUNOLOGY; MICROBIOLOGY; MOUSE MUTANT; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

FILOBASIDIELLA NEOFORMANS; FUNGI; MUS;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CRYPTOCOCCUS NEOFORMANS; MACROPHAGES, ALVEOLAR; MICE; MICE, KNOCKOUT; PHAGOCYTOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RATS; RATS, SPRAGUE-DAWLEY;

EID: 44449126226     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001370     Document Type: Article

References (28)

1. Mitchell TG, Perfect JR (1995) Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8: 515-548.
2. Tino MJ, Wright JR (1996) Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol 270: L677-688.
3. Ghildyal R, Hartley C, Varrasso A, Meanger J, Voelker DR, et al. (1999) Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. J Infect Dis 180: 2009-2013.
4. Hartshorn KL, White MR, Shepherd V, Reid K, Jensenius JC, et al. (1997) Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol 273: L1156-1166.
5. Madan T, Eggleton P, Kishore U, Strong P, Aggrawal SS, et al. (1997) Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 65: 3171-3179.
6. McCormack FX, Festa AL, Andrews RP, Linke M, Walzer PD (1997) The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pheumocystis carinii. Biochemistry 36: 8092-8099.
7. Crouch E, Wright JR (2001) Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 63: 521-554.
8. Wright JR (1997) Immunomodulatory functions of surfactant. Physiol Rev 77: 931-962.
9. Wright JR (2005) Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5: 58-68.
10. Schelenz S, Malhotra R, Sim RB, Holmskov U, Bancroft GJ (1995) Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun 63: 3360-3366.
11. Waleakamp AM, Verheul AF, Scharringa J, Hoepelman IM (1999) Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis. Eur J Clin Invest 29: 83-92.
12. Alcorn JF, Wright JR (2004) Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway. Am J Physiol Lung Cell Mol Physiol 286: L129-136.
13. Giles SS, Batinic-Haberle I, Perfect JR, Cox GM (2005) Cryptococcus neoformans mitochondrial superoxide dismutase: an essential link between antioxidant function and high-temperature growth. Eukaryot Cell 4: 46-54.
14. Giles SS, Perfect JR, Cox GM (2005) Cytochrome c peroxidase contributes to the antioxidam defense of Cryptococcus neoformans. Fungal Genet Biol 42: 20-29.
15. Giles SS, Stajich JE, Nichols C, Gerrald QD, Alspaugn JA, et al. (2006) The Cryptococcus neoformans Catalase Gene Family and Its Role in Antioxidant Defense. Eukaryot Cell 5: 1447-1459.
16. Zaragoza O, Casadevall A (2006) Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance. Cell Microbiol 8: 1862-1876.
17. Zimmerman PE, Voelker DR, McCormack FX, Paulsrud JR, Martin WJ 2nd (1992) 120-kD surface glycoprotein of Pneumocysis carinü is a ligand for surfactant protein A. J Clin Invest 89: 143-149.
18. Awastin S, Magee DM, Coalson JJ (2004) Coccidioides posadasii infection alters the expression of pulmonary surfactant proteins (SP)-A and SP-D. Respir Res 5: 28.
19. McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, et al. (2003) Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 278: 36250-36256.
20. Allen MJ, Voelker DR, Mason RJ (2001) Interactions of surfactant proteins A and D with Saccharomyces cereviviae and Aspergillus fumigatus. Infect Immun 69: 2037-2044.
21. Haurum JS, Thiel S, Haagsman HP, Laursen SB, Larsen B, et al. (1993) Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein A and comparison with two other collectins: mannan-binding protein and conglutinin. Biochem J 293(Pt 3): 873-878.
22. Cruickshank JG, Cavill R, Jelbert M (1973) Cryptococcus neoformans of unusual morphology. Appl Microbiol 25: 309-312.
23. Granger DL, Perfect JR, Durack DT (1985) Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest 76: 508-516.
24. Nosanchuk JD, Casadevall A (1997) Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect Immun 65: 1836-1841.
25. Lin PM, Wright JR (2006) Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes. Am J Physiol Lung Cell Mol Physiol 291: L1199-1206.
26. Kishor U, Madan T, Sarma PU, Singh M, Urban BC, et al. (2002) Protective roles of pulmonary surfactant proteins, SP-A and SP-D, against lung allergy and infection caused by Aspergillus fumigalus. Immunobiology 205: 610-618.
27. Atochina EN, Beck JM, Preston AM, Haczku A, Tomer Y, et al. (2004) Enhanced lung injury and delayed clearance of Pneumocystis carinü in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun 72: 6002-6011.
28. Crowther JE, Kutala VK, Kuppusamy P, Ferguson JS, Beharka AA, et al. (2004) Pulmonary surfactant protein A inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol 172: 6866-6874.